Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
- C
- C
- C
Lists including Aditya
Work Experience
2018
CEO, Chairman, Co-Founder
2018
Caltech spin-out utilizing compressed sensing methods with ultrasound to continuously and non-invasively measure blood pressure. Backed by Maverick Ventures and others.
2012
Founder & Chairman
2012
We are a multiplexed molecular diagnostics company with a bioinformatics focus and pedigree from Google[x], Illumina, Luminex, and Caltech. We are transforming the multi-billion dollar molecular diagnostics industry by democratizing personalized medicine. I am the Founder and Member of the Board of Directors of ChromaCode, and the inventor of core technologies related to combinatorics for biochemical labeling, multiplexed PCR assay design, and algorithms for data processing. Served as CTO from 2012 - 2024.
Chairperson
2024
Enabling dental offices with better patient diagnostics.
2020
Independent Board Director
2020
Camena Bioscience utilizes novel "geometric synthesis" methods to build oligo nucleotides for synthetic biology with significantly higher length and purity. Advisor to Board of Directors and CEO (2020 - 2023) Independent Board Director (2023 - present)
2022
Advisor
2022
2016
Visiting Associate (Visiting Faculty)
2016
I lead, fund, and manage a research group working on interesting things at the nexus of biology, medicine, and engineering. HDPCR (commercialized by ChromaCode) is the first technology to be transitioned into industry from our lab. Compressed sensing with ultrasound (commercialized by Esperto Medical) is the second.
Adjunct Assistant Professor, Biomedical Engineering
2018
I work on interesting problems related to fluorescence imaging methods.
2018 - 2024
Advisor
2018 - 2024
LunaPBC is the first community-owned health and DNA data platform dedicated to advancing research through community engagement, and personal data ownership, control and transparency. Founded by former executive leadership from Illumina and funded by Illumina Ventures and Arch Ventures. Serve as an advisor to the founders of the company.
2020 - 2022
Venture Partner
2020 - 2022
Investing at the nexus of data science, physical science, and life science. ND Capital investments include: Public: TWST, ARMO, SQZ Private: Visby, Inscripta
2018 - 2020
Visting Scholar, Canary Institute for Early Cancer Detection
2018 - 2020